EN1 and breast cancer: We found that methylation of the BLAT1 CpG site, cg18250846, is significantly correlated with the methylation status at three sites in the EN1 promoter (cg20248516, cg22030072, and cg17167253) in breast cancer (p < 0.0001) (Supplementary Fig. 1C).